DENTSPLY SIRONA Inc. ($XRAY) Stock Forecast: Down 25.2% Today

What is DENTSPLY SIRONA Inc.?

Dentsply Sirona (NASDAQ: XRAY) Market Dentsply Sirona is a leading manufacturer of professional dental products and technologies. The company operates globally and provides a wide range of dental solutions to healthcare professionals.

Why is DENTSPLY SIRONA Inc. going down?

XRAY stock is down 25.2% on Nov 7, 2024 18:06

• Despite exceeding earnings and revenue expectations in the third quarter, Dentsply Sirona's stock faced downward pressure following a revised guidance for fiscal 2024.
• The revised forecast for 2024, attributed to macroeconomic factors, competition, and lower demand, elicited concerns among investors and led to a decline in the stock price.
• The market response may reflect apprehension surrounding future growth despite positive performance in specific segments during the quarter.
• Investors appear to be adopting a wary stance towards Dentsply Sirona until there is more clarity on the company's strategies to tackle the challenges affecting its future financial outlook.

XRAY Price Chart

XRAY Technical Analysis

XRAY News

Dentsply Sirona Stock Sinks On Dismal 2024 Guidance, Blames Macroeconomic, Competitive Pressures And Weakened Demand - Dentsply Sirona ( NASDAQ:XRAY )

The company reported third-quarter adjusted earnings per share of 50 cents, beating the street view of 47 cents. Quarterly sales of $951 million ( increased 0.5% ) outpaced the analyst consensus estimate of $939.10 million.

https://www.benzinga.com/analyst-ratings/analyst-color/24/11/41814727/dentsply-sirona-stock-sinks-on-dismal-2024-guidance-blames-macroeconomic-competitiv

XRAY Q3 Earnings & Revenues Beat Estimates, 2024 Guidance Revised

DENTSPLY SIRONA's third-quarter results showcase strong top-line growth in the Essential Dental Solutions segment. However, the lowered outlook for fiscal 2024 is a cause of concern.

https://www.zacks.com/stock/news/2366601/xray-q3-earnings-revenues-beat-estimates-2024-guidance-revised

Should You Buy, Sell or Hold DENTSPLY SIRONA Before Q3 Earnings?

XRAY's third-quarter results are likely to reflect growth in the Wellspect Healthcare business and Orthodontic segment amid foreign exchange headwinds.

https://www.zacks.com/stock/news/2364091/should-you-buy-sell-or-hold-dentsply-sirona-before-q3-earnings

Trending Today

FuelCell Energy ($FCEL) Stock Forecast: Up 5.6% Today

Dogecoin ($DOGE) Crypto Forecast: Up 5.2% Today

XRP ($XRP) Crypto Forecast: Up 29.6% Today

Airbnb Inc. ($ABNB) Stock Forecast: Up 5.6% Today

Cardano ($ADA) Crypto Forecast: Up 16.9% Today

Xerox Corporation ($XRX) Stock Forecast: Up 8.6% Today

Solana ($SOL) Crypto Forecast: Up 5.0% Today

Avalanche ($AVAX) Crypto Forecast: Up 11.3% Today

American Eagle Outfitters Inc. ($AEO) Stock Forecast: Up 5.1% Today

Zoom Video Communications Inc. ($ZM) Stock Forecast: Up 5.2% Today

DENTSPLY SIRONA Inc. Price History

20.07.2024 - XRAY Stock was down 5.1%

• The bearish movement in XRAY stock today could be attributed to the unexpected departure of CFO Glenn Coleman, leading to uncertainty among investors.
• Investors may be concerned about the implications of a key executive leaving the company, potentially signaling internal issues or strategic changes.
• The departure of a CFO can sometimes indicate financial challenges or mismanagement, causing investors to react negatively and sell off shares of the company.

03.10.2023 - XRAY Stock was up 5.5%

• The bullish movement in XRAY stock today can be attributed to the following factors:
• 1. Strong Q3 earnings: XRAY beat expectations in its Q3 earnings, driven by increased demand for aligners and CAD/CAM in the United States, as well as a recovery in demand in China.
• 2. Revised annual outlook: Despite the challenging macroeconomic conditions, XRAY revised its annual outlook, which may have instilled confidence in investors and contributed to the bullish movement.
• 3. Appointment of new board member: The announcement of Mr. Brian Gladden's appointment to the Board of Directors may have signaled positive changes within the company, boosting investor sentiment.
• 4. Market reaction to previous dip: XRAY shares had previously dipped due to the company's reduced outlook for the year. The bullish movement today could be a result of investors seeing an opportunity to buy the stock at a lower price.
• Overall, the combination of strong earnings, revised outlook, positive board appointment, and market reaction to the previous dip likely contributed to the bullish movement in XRAY stock today.

14.10.2023 - XRAY Stock was up 5.0%

• XRAY had a strong bullish movement today, possibly driven by the announcement of their participation in upcoming investor conferences. This indicates potential positive developments or opportunities for the company.
• Additionally, the news about Dentsply Sirona's new $1B share buyback program could have boosted investor confidence and contributed to the bullish market movement.
• The company's plans for above-consensus earnings by 2026 might have also attracted investors, further driving the bullish sentiment.
• Overall, the combination of positive conference participation, share buyback program, and earnings outlook likely influenced the bullish market movement for XRAY.

29.01.2024 - XRAY Stock was down 5.4%

• Despite higher sales reported for Q4 2023, the market may have reacted bearishly due to a net loss for FY23.
• The departure of a board member might have added to the negative sentiment surrounding the stock, signaling potential internal challenges.
• The mixed FY24 guidance offered by Dentsply Sirona could have contributed to investor uncertainty, leading to the bearish market movement.
• Overall, the combination of a net loss, board member departure, and uncertain future guidance likely influenced the bearish trend in XRAY stock today.

01.02.2024 - XRAY Stock was down 5.4%

• Despite higher sales for Q4 2023, Dentsply Sirona Inc. (XRAY) witnessed a strong bearish movement in the stock market today.
• The market reaction to the company's net loss for FY23, despite modest revenue growth, was negative.
• The upcoming departure of a board member might have also contributed to the bearish sentiment surrounding XRAY.
• Mention of challenging macro headwinds in the earnings report could have further reduced investor confidence, influencing the bearish market movement.

29.01.2024 - XRAY Stock was down 1.5%

• The bearish movement in XRAY stock could be attributed to the mixed FY24 guidance provided by Dentsply Sirona, despite posting a Q4 earnings beat.
• The net loss reported for FY23 amidst modest revenue growth might have also contributed to the negative sentiment surrounding the stock.
• The upcoming departure of a board member, Eric K. Brandt, could have added uncertainty and potential instability to the company's leadership, impacting investor confidence.
• Despite reporting higher sales for Q4 2023, the overall market reaction to the earnings summary may have been overshadowed by concerns over the company's financial performance and future outlook.

02.09.2024 - XRAY Stock was down 5.5%

• The decline in XRAY's stock price could be linked to various macroeconomic challenges, including weakened global demand, increased costs, and currency fluctuations.
• Despite its diverse product portfolio, these external factors appear to have impacted investor sentiment, leading to the stock's downturn.
• Investors may remain wary about the company's future performance until there is more clarity on DENTSPLY SIRONA's strategy to address the current economic challenges.

25.09.2024 - XRAY Stock was down 5.3%

• Dentsply Sirona's decision to voluntarily suspend sales and marketing of Byte Aligners and Impression Kits could have raised concerns among investors about the company's revenue stream and future growth prospects.
• The upcoming conference call to discuss updates on Byte Aligner products might have failed to reassure investors, leading to a lack of confidence in the company's ability to address the issues effectively.
• The select preliminary third-quarter results provided by Dentsply Sirona could have indicated weaker performance than expected, contributing to the negative sentiment surrounding the stock.

13.08.2024 - XRAY Stock was up 5.2%

• The launch of Primescan 2, the new-generation intraoral scanner, is anticipated to fuel growth and market sentiment for XRAY.
• The innovative technology is expected to draw in more customers and bolster the company's competitiveness in the dental equipment sector.
• Investors are positive about the potential rise in revenue and enhanced customer satisfaction resulting from Primescan 2, contributing to today's bullish market movement.

07.10.2024 - XRAY Stock was down 25.2%

• Despite exceeding earnings and revenue expectations in the third quarter, Dentsply Sirona's stock faced downward pressure following a revised guidance for fiscal 2024.
• The revised forecast for 2024, attributed to macroeconomic factors, competition, and lower demand, elicited concerns among investors and led to a decline in the stock price.
• The market response may reflect apprehension surrounding future growth despite positive performance in specific segments during the quarter.
• Investors appear to be adopting a wary stance towards Dentsply Sirona until there is more clarity on the company's strategies to tackle the challenges affecting its future financial outlook.

07.10.2024 - XRAY Stock was down 19.9%

• The bearish movement in XRAY could be due to investors anticipating weaker-than-expected third-quarter earnings.
• Despite growth in specific segments like Wellspect Healthcare and Orthodontics, foreign exchange headwinds may have impacted overall performance.
• Investors might be taking a cautious approach, leading to a sell-off of XRAY shares before the earnings report.
• The uncertainty surrounding the company's financial performance in the face of external challenges could be driving the bearish sentiment in the market.

02.07.2024 - XRAY Stock was down 5.0%

• Second-quarter earnings of Dentsply Sirona (XRAY) were below analysts' expectations, with adjusted earnings per share and sales failing to meet estimates.
• Investor concerns about weak demand prompted the company to launch a restructuring plan, potentially impacting the stock's performance.
• Comparing the current figures to the previous year, the company experienced a decrease in both earnings and sales, influencing the negative market sentiment towards XRAY.
• Despite intentions to boost performance and shareholder value through restructuring and leadership adjustments, the initial reaction from investors may have triggered the downward movement in the stock price.